Xocova (ensitrelvir) is the first FDA-approved oral COVID post-exposure pill, cutting risk by 67% in the SCORPIO-PEP Phase 3 trial. What high-risk patients need to know.
FDA Approves Xocova (Ensitrelvir): The First Oral COVID Pill You Take After Exposure — Before You Get Sick
by | Jun 17, 2026 | Uncategorized | 0 comments
Recent Comments